Hosking D - Search Results

1

Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.

Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D. Reid IR, et al. Among authors: hosking d. N Engl J Med. 2005 Sep 1;353(9):898-908. doi: 10.1056/NEJMoa044241. N Engl J Med. 2005. PMID: 16135834 Free article. Clinical Trial.

2

A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years.

Reid IR, Lyles K, Su G, Brown JP, Walsh JP, del Pino-Montes J, Miller PD, Fraser WD, Cafoncelli S, Bucci-Rechtweg C, Hosking DJ. Reid IR, et al. Among authors: hosking dj. J Bone Miner Res. 2011 Sep;26(9):2261-70. doi: 10.1002/jbmr.438. J Bone Miner Res. 2011. PMID: 21638319 Free article.

3

Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.

Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR. Hosking D, et al. J Bone Miner Res. 2007 Jan;22(1):142-8. doi: 10.1359/jbmr.061001. J Bone Miner Res. 2007. PMID: 17032148 Free article. Clinical Trial.

4

Bisphosphonates in Paget's disease.

Reid IR, Hosking DJ. Reid IR, et al. Among authors: hosking dj. Bone. 2011 Jul;49(1):89-94. doi: 10.1016/j.bone.2010.09.002. Epub 2010 Sep 9. Bone. 2011. PMID: 20832512 Review.

5

Paget's disease of bone: an endocrine society clinical practice guideline.

Singer FR, Bone HG 3rd, Hosking DJ, Lyles KW, Murad MH, Reid IR, Siris ES; Endocrine Society. Singer FR, et al. J Clin Endocrinol Metab. 2014 Dec;99(12):4408-22. doi: 10.1210/jc.2014-2910. J Clin Endocrinol Metab. 2014. PMID: 25406796

6

Zoledronate.

Reid IR, Green JR, Lyles KW, Reid DM, Trechsel U, Hosking DJ, Black DM, Cummings SR, Russell RGG, Eriksen EF. Reid IR, et al. Among authors: hosking dj. Bone. 2020 Aug;137:115390. doi: 10.1016/j.bone.2020.115390. Epub 2020 Apr 27. Bone. 2020. PMID: 32353565

7

Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial.

Reid IR, Nicholson GC, Weinstein RS, Hosking DJ, Cundy T, Kotowicz MA, Murphy WA Jr, Yeap S, Dufresne S, Lombardi A, Musliner TA, Thompson DE, Yates AJ. Reid IR, et al. Among authors: hosking dj. Am J Med. 1996 Oct;101(4):341-8. doi: 10.1016/s0002-9343(96)00227-6. Am J Med. 1996. PMID: 8873503 Clinical Trial.

8

Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study.

Buckler H, Fraser W, Hosking D, Ryan W, Maricic MJ, Singer F, Davie M, Fogelman I, Birbara CA, Moses AM, Lyles K, Selby P, Richardson P, Seaman J, Zelenakas K, Siris E. Buckler H, et al. Among authors: hosking d. Bone. 1999 May;24(5 Suppl):81S-85S. doi: 10.1016/s8756-3282(99)00071-x. Bone. 1999. PMID: 10321935 Free article. Clinical Trial. No abstract available.

9

Risedronate, a highly effective, short-term oral treatment for Paget's disease: a dose-response study.

Brown JP, Hosking DJ, Ste-Marie L, Johnston CC Jr, Reginster J, Ryan WG, Johnson TD, Bekker PJ. Brown JP, et al. Among authors: hosking dj. Calcif Tissue Int. 1999 Feb;64(2):93-9. doi: 10.1007/s002239900584. Calcif Tissue Int. 1999. PMID: 9914313 Clinical Trial.

10

Response to letter by Ralston et al.

Singer FR, Bone HG 3rd, Hosking DJ, Lyles KW, Reid IR, Siris ES. Singer FR, et al. J Clin Endocrinol Metab. 2015 Jun;100(6):L47-8. doi: 10.1210/jc.2015-1961. J Clin Endocrinol Metab. 2015. PMID: 26047081 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters